JIUTAI RCB's performance forecast for 2023: Implement relief measures to support enterprises, reduce fees and provide support to real economy.
Implement relief measures to support enterprises, reduce fees, offer incentives, and support the real economy.
On March 15th, JIUTAI RCB (06122) announced its performance forecast for 2023. The announcement indicates that, in order to support stable growth, implement relief measures for enterprises, reduce fees, and support the real economy, coupled with factors such as the decline in market interest rates, the progress of business recovery after the pandemic, the transformation of old and new economic drivers in the region, and increased provisions for asset impairment, it is expected that JIUTAI RCB's net profit will decrease by about 85% compared to the same period last year. JIUTAI RCB stated that in the future, it will fully grasp the opportunities of the macroeconomic recovery, solidly promote the transformation of methods, adjustment of structure, improvement of quality, and enhancement of efficiency, and steadily improve its operational performance.
Public information shows that JIUTAI RCB ranked 472nd in the 2023 Global Top 1000 Banks list published by the British magazine "The Banker."
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


